1. Home
  2. VRNA vs CAMT Comparison

VRNA vs CAMT Comparison

Compare VRNA & CAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • CAMT
  • Stock Information
  • Founded
  • VRNA 2005
  • CAMT 1987
  • Country
  • VRNA United Kingdom
  • CAMT Israel
  • Employees
  • VRNA N/A
  • CAMT N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • CAMT Electronic Components
  • Sector
  • VRNA Health Care
  • CAMT Technology
  • Exchange
  • VRNA Nasdaq
  • CAMT Nasdaq
  • Market Cap
  • VRNA 3.4B
  • CAMT 3.9B
  • IPO Year
  • VRNA 2017
  • CAMT 2000
  • Fundamental
  • Price
  • VRNA $67.96
  • CAMT $76.39
  • Analyst Decision
  • VRNA Strong Buy
  • CAMT Strong Buy
  • Analyst Count
  • VRNA 7
  • CAMT 8
  • Target Price
  • VRNA $57.14
  • CAMT $113.38
  • AVG Volume (30 Days)
  • VRNA 1.3M
  • CAMT 674.6K
  • Earning Date
  • VRNA 02-27-2025
  • CAMT 02-12-2025
  • Dividend Yield
  • VRNA N/A
  • CAMT 1.74%
  • EPS Growth
  • VRNA N/A
  • CAMT 48.32
  • EPS
  • VRNA N/A
  • CAMT 2.42
  • Revenue
  • VRNA $5,624,000.00
  • CAMT $429,234,000.00
  • Revenue This Year
  • VRNA N/A
  • CAMT $16.55
  • Revenue Next Year
  • VRNA $571.44
  • CAMT $10.88
  • P/E Ratio
  • VRNA N/A
  • CAMT $33.01
  • Revenue Growth
  • VRNA 1127.95
  • CAMT 36.10
  • 52 Week Low
  • VRNA $11.39
  • CAMT $69.83
  • 52 Week High
  • VRNA $68.64
  • CAMT $140.50
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 76.88
  • CAMT 34.70
  • Support Level
  • VRNA $62.24
  • CAMT $83.22
  • Resistance Level
  • VRNA $65.50
  • CAMT $90.50
  • Average True Range (ATR)
  • VRNA 2.78
  • CAMT 4.99
  • MACD
  • VRNA 0.22
  • CAMT -1.65
  • Stochastic Oscillator
  • VRNA 94.86
  • CAMT 10.25

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About CAMT Camtek Ltd.

Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.

Share on Social Networks: